Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06218914
Title A Study of NT-112 in HLA-C*08:02-Positive Adult Subjects With Unresectable, Advanced, and/ or Metastatic Solid Tumors Positive for the KRAS G12D Mutation
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Neogene Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope RECRUITING Duarte California 91010 United States Details
UCLA Health Jonsson Comprehensive Cancer Center RECRUITING Los Angeles California 90024 United States Details
Hoag Hospital Newport Beach RECRUITING Newport Beach California 92658 United States Details
University of Kansas Cancer Center - Westwood Campus RECRUITING Fairway Kansas 66205 United States Details
Washington University School of Medicine in St. Louis RECRUITING St. Louis Missouri 63110 United States Details
NYU Langone Health RECRUITING New York New York 10016 United States Details
Providence Portland Medical Center RECRUITING Portland Oregon 97213 United States Details
UPMC Hillman Cancer Center RECRUITING Pittsburgh Pennsylvania 15232 United States Details
Sarah Cannon Research Institute RECRUITING Nashville Tennessee 37203 United States Details
Baylor Scott & White Health / Texas Oncology, PA RECRUITING Dallas Texas 75246 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Medical College of Wisconsin Cancer Center RECRUITING Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field